Hepatitis C, Chronic, Personality Disorders in Prison
Conditions
Keywords
prison, disorder, hepatitis c
Brief summary
Primary objective: Evaluate the prevalence of personality disorders in patients starting treatment for hepatitis C in the prison and determine their influence on the evolution of the disease.
Detailed description
Secondary objectives: * Describe the management of patients with personality disorders on treatment for hepatitis C in the prison. * Describe the characteristics of patients who discontinue the treatment and the reasons for stratifying by the presence of personality disorders.
Interventions
OTHERPeginterferon alfa-2a
Treatment as usual clinical practice
DRUGRibavirin
Treatment as usual clinical practice
Sponsors
Grupo de Enfermedades Infecciosas de la Sociedad Española de Sanidad Penitenciaria
Study design
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Patients 18 years of age. * Patients with expected prison stay beyond the duration of follow-up period of the study. * Patients with chronic HCV infection and detectable viral load to initiate treatment with standard therapy. * Patients their written informed consent to participate in the study.
Exclusion criteria
* Patients previously treated with Interferon (IFN) and Ribavirin (RBV). * Patients can not read or understand a written questionnaire at the discretion of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sustained Viral Response (SVR) | RNA-VHC at weeks 24 or 48 |
Countries
Spain
Outcome results
None listed